Abstract
Background & aims
Adherent-invasive Escherichia coli (AIEC) pathovar has been identified in the intestinal mucosa of patients with Crohn's disease (CD). AIEC reference strain LF82 is able to adhere to intestinal epithelial cells, to invade epithelial cells via a mechanism involving actin polymerization and microtubules, and to survive and replicate within macrophages. This study was performed to assess the prevalence of AIEC associated with intestinal mucosa of patients with CD, ulcerative colitis (UC), and of controls.Methods
A search for E. coli strains was performed with ileal specimens of 63 patients with CD and 16 controls without inflammatory bowel disease (IBD), and with colonic specimens of 27 patients with CD, 8 patients with UC, and 102 controls. The abilities of E. coli strains to invade epithelial cells and to survive and replicate within macrophages were assessed using the gentamicin protection assay. Bacterial uptake by epithelial cells was analyzed using cytoskeletal inhibitors. Bacterial adhesion was quantified with Caco-2 and Intestine-407 cells. The presence of known E. coli virulence genes was assessed by polymerase chain reaction and DNA hybridization.Results
In ileal specimens, AIEC strains were found in 21.7% of CD chronic lesions vs. in 6.2% of controls. In neoterminal ileal specimens, AIEC strains were found in 36.4% of CD early lesions (P = 0.034 vs. controls) and 22.2% of healthy mucosa of CD patients. In colonic specimens, AIEC strains were found in 3.7% of CD patients, 0% of UC patients, and 1.9% of controls.Conclusions
AIEC strains are associated specifically with ileal mucosa in CD.Full text links
Read article at publisher's site: https://doi.org/10.1053/j.gastro.2004.04.061
Read article for free, from open access legal sources, via Unpaywall: http://www.gastrojournal.org/article/S0016508504007711/pdf
References
Articles referenced by this article (50)
Microbial factors in chronic intestinal inflammation
Curr Opin Gastroenterol 1996
Granulomatous infections: etiology and classification.
Clin Infect Dis, (1):146-158 1996
MED: 8816144
A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID).
Am J Gastroenterol, (3):674-678 1999
MED: 10086650
Combination ciprofloxacin and metronidazole for active Crohn's disease.
Can J Gastroenterol, (1):53-56 1998
MED: 9544412
Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study.
Gastroenterology, (5):1072-1078 1998
MED: 9797360
An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.
Am J Gastroenterol, (2):328-332 1996
MED: 8607501
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.
Gastroenterology, (6):1617-1621 1995
MED: 7768364
Show 10 more references (10 of 50)
Citations & impact
Impact metrics
Article citations
Antimicrobial Peptides (AMPs) and the Microbiome in Preterm Infants: Consequences and Opportunities for Future Therapeutics.
Int J Mol Sci, 25(12):6684, 18 Jun 2024
Cited by: 0 articles | PMID: 38928389
Review
The Impact of Dietary Interventions on the Microbiota in Inflammatory Bowel Disease: A Systematic Review.
J Crohns Colitis, 18(6):920-942, 01 Jun 2024
Cited by: 2 articles | PMID: 38102104 | PMCID: PMC11147801
Review Free full text in Europe PMC
Contribution of Toxin-Antitoxin Systems to Adherent-Invasive E. coli Pathogenesis.
Microorganisms, 12(6):1158, 06 Jun 2024
Cited by: 0 articles | PMID: 38930540
Review
Dysbiosis in inflammatory bowel diseases: egg, not chicken.
Front Med (Lausanne), 11:1395861, 23 May 2024
Cited by: 0 articles | PMID: 38846142 | PMCID: PMC11153678
Review Free full text in Europe PMC
Inflammatory proteins may mediate the causal relationship between gut microbiota and inflammatory bowel disease: A mediation and multivariable Mendelian randomization study.
Medicine (Baltimore), 103(25):e38551, 01 Jun 2024
Cited by: 0 articles | PMID: 38905376 | PMCID: PMC11191895
Go to all (937) article citations
Other citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease.
Inflamm Bowel Dis, 15(6):872-882, 01 Jun 2009
Cited by: 254 articles | PMID: 19235912
Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease.
Inflamm Bowel Dis, 18(5):913-924, 12 Oct 2011
Cited by: 71 articles | PMID: 21994005
Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features.
BMC Res Notes, 7:748, 22 Oct 2014
Cited by: 49 articles | PMID: 25338542 | PMCID: PMC4210564
Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease.
Int J Med Microbiol, 292(3-4):185-193, 01 Sep 2002
Cited by: 93 articles | PMID: 12398209
Review
Pathogens in Crohn's Disease: The Role of Adherent Invasive Escherichia coli.
Crit Rev Eukaryot Gene Expr, 34(3):83-99, 01 Jan 2024
Cited by: 1 article | PMID: 38305291
Review